Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 38.81%775.42M | ---- | 1.11%558.62M | ---- | -31.54%552.51M | ---- | 160.46%807.04M | ---- | -4.38%309.86M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -123.43%-24.31M | ---- | -98.45%-10.88M | ---- | -1,992.37%-5.48M | ---- | 80.40%-262K | ---- | 75.88%-1.34M |
| Impairment and provisions: | ---- | 22.92%39.65M | ---- | 11.70%32.25M | ---- | -17.13%28.88M | ---- | 45.26%34.84M | ---- | 499.23%23.99M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --5.68M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.12M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -129.61%-2.25M | ---- | 6,231.45%7.6M | ---- | ---124K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 69.97%41.9M | ---- | 5.69%24.65M | ---- | -28.73%23.32M | ---- | 36.42%32.72M | ---- | 499.23%23.99M |
| Revaluation surplus: | ---- | 229.89%28.94M | ---- | 142.61%8.77M | ---- | -617.08%-20.59M | ---- | -90.49%3.98M | ---- | 889.18%41.87M |
| -Other fair value changes | ---- | 229.89%28.94M | ---- | 142.61%8.77M | ---- | -617.08%-20.59M | ---- | -90.49%3.98M | ---- | 889.18%41.87M |
| Asset sale loss (gain): | ---- | -397.01%-199K | ---- | -72.20%67K | ---- | -96.43%241K | ---- | 1,553.19%6.75M | ---- | 36.00%408K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -397.01%-199K | ---- | -72.20%67K | ---- | -96.43%241K | ---- | 1,553.19%6.75M | ---- | 36.00%408K |
| Depreciation and amortization: | ---- | -8.88%192.46M | ---- | -10.99%211.22M | ---- | 13.07%237.3M | ---- | 35.96%209.86M | ---- | 40.01%154.36M |
| -Amortization of intangible assets | ---- | -44.94%8.02M | ---- | 3.40%14.56M | ---- | 135.89%14.09M | ---- | 4,165.00%5.97M | ---- | -84.14%140K |
| Financial expense | ---- | -65.40%11.35M | ---- | -3.31%32.8M | ---- | -9.10%33.92M | ---- | 0.79%37.32M | ---- | 122.27%37.02M |
| Exchange Loss (gain) | ---- | -436.48%-3.56M | ---- | -35.53%1.06M | ---- | 183.00%1.64M | ---- | -135.53%-1.98M | ---- | 333.00%5.56M |
| Special items | ---- | -83.21%1.22M | ---- | 118.58%7.27M | ---- | 238.34%3.33M | ---- | -45.05%-2.41M | ---- | -365.73%-1.66M |
| Operating profit before the change of operating capital | ---- | 21.37%1.02B | ---- | 1.13%841.18M | ---- | -24.05%831.74M | ---- | 92.11%1.1B | ---- | 25.33%570.07M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 167.32%23.7M | ---- | -185.13%-35.2M | ---- | 123.10%41.35M | ---- | -26.65%-178.99M | ---- | -1,495.75%-141.33M |
| Accounts receivable (increase)decrease | ---- | 252.55%22.19M | ---- | 72.02%-14.55M | ---- | 78.98%-51.99M | ---- | -349.22%-247.34M | ---- | 254.29%99.25M |
| Accounts payable increase (decrease) | ---- | -1,900.95%-148.17M | ---- | -105.89%-7.41M | ---- | 4,889.21%125.83M | ---- | -92.10%2.52M | ---- | 48.49%31.92M |
| Special items for working capital changes | ---- | 248.29%3.87M | ---- | 115.18%1.11M | ---- | -253.62%-7.33M | ---- | 71.85%-2.07M | ---- | -167.19%-7.36M |
| Cash from business operations | ---- | 17.50%922.55M | ---- | -16.44%785.14M | ---- | 40.40%939.61M | ---- | 21.12%669.25M | ---- | 27.57%552.55M |
| Other taxs | ---- | 24.78%-147.33M | ---- | -24.68%-195.86M | ---- | -18.22%-157.09M | ---- | -89.57%-132.87M | ---- | -8.87%-70.09M |
| Special items of business | 27.30%525.9M | ---- | -10.95%413.12M | ---- | 67.56%463.92M | ---- | -25.10%276.86M | ---- | 430.55%369.66M | ---- |
| Net cash from operations | 27.30%525.9M | 31.55%775.22M | -10.95%413.12M | -24.70%589.28M | 67.56%463.92M | 45.89%782.52M | -25.10%276.86M | 11.18%536.38M | 430.55%369.66M | 30.84%482.45M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 81.30%15.85M | 123.43%24.31M | 178.55%8.74M | 98.45%10.88M | 1,469.00%3.14M | 1,992.37%5.48M | -53.05%200K | -80.40%262K | -44.82%426K | -75.88%1.34M |
| Restricted cash (increase) decrease | 3.33%590K | 2.31%-593K | 135.82%571K | 41.91%-607K | -217.53%-1.59M | -9.20%-1.05M | -197.86%-502K | -126.23%-957K | 143.40%513K | 185.75%3.65M |
| Loan receivable (increase) decrease | --606K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -73.53%63K |
| Decrease in deposits (increase) | -158.53%-58.53M | 232.28%105.83M | 211.11%100M | -166.67%-80M | ---90M | ---30M | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -3.17%1.04M | -39.89%2.28M | --1.07M | --3.79M | ---- | ---- | ---- | 33.39%803K | ---- | 1,014.81%602K |
| Purchase of fixed assets | -26.47%-105.75M | -33.57%-211.27M | 0.87%-83.62M | -215.45%-158.18M | -507.42%-84.35M | 75.48%-50.14M | 83.43%-13.89M | -43.59%-204.5M | -25.52%-83.83M | 65.11%-142.42M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -266.77%-75M |
| Cash on investment | ---5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.08%1.44M |
| Net cash from investment operations | -664.90%-151.2M | 64.55%-79.46M | 115.49%26.77M | -196.04%-224.12M | -1,117.90%-172.81M | 62.96%-75.71M | 82.88%-14.19M | 2.82%-204.39M | -23.42%-82.89M | 49.93%-210.33M |
| Net cash before financing | -14.82%374.71M | 90.54%695.76M | 51.11%439.88M | -48.34%365.16M | 10.83%291.11M | 112.90%706.82M | -8.40%262.67M | 22.00%331.99M | 11,325.02%286.77M | 630.00%272.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 19.65%59.83M | 0.00%50M | -80.00%50M | -58.33%50M | -52.83%250M | -71.83%120M | 135.56%530M | 89.33%426M | -57.60%225M |
| Refund | 70.15%-20M | 48.92%-205.09M | 31.28%-67M | 32.42%-401.5M | 35.00%-97.5M | 17.35%-594.13M | 67.43%-150M | -100.12%-718.85M | -610.59%-460.49M | 9.60%-359.21M |
| Issuing shares | ---- | --124.89M | --124.08M | ---- | ---- | ---- | ---- | --126.89M | --126.89M | ---- |
| Interest paid - financing | 93.28%-363K | 61.95%-11.84M | 67.89%-5.4M | 1.26%-31.12M | -25.28%-16.82M | 8.92%-31.52M | 23.46%-13.42M | 32.78%-34.6M | 39.60%-17.54M | 16.90%-51.48M |
| Dividends paid - financing | -200.57%-20M | 34.71%-139.72M | 87.36%-6.65M | -9.11%-214M | -263.50%-52.63M | -61.37%-196.13M | 1.66%-14.48M | -109.17%-121.54M | 53.99%-14.72M | -36.39%-58.11M |
| Issuance expenses and redemption of securities expenses | ---- | ---811K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -144.38%-42.1M | 71.39%-173.02M | 178.78%94.86M | -4.43%-604.66M | -96.54%-120.41M | -157.28%-579M | -208.20%-61.26M | 9.96%-225.05M | -41.26%56.62M | -969.42%-249.94M |
| Effect of rate | 217.30%2.16M | 436.29%3.56M | 170.31%682K | 35.53%-1.06M | ---970K | -183.00%-1.64M | ---- | 135.53%1.98M | 97.90%-18K | -333.00%-5.56M |
| Net Cash | -37.80%332.61M | 318.26%522.74M | 213.26%534.74M | -287.38%-239.5M | -15.25%170.7M | 19.52%127.82M | -41.35%201.41M | 382.08%106.94M | 247.21%343.39M | 198.17%22.18M |
| Begining period cash | 106.89%1.02B | -32.82%492.36M | -32.82%492.36M | 20.80%732.92M | 20.80%732.92M | 21.88%606.75M | 21.88%606.75M | 3.45%497.83M | 3.45%497.83M | -4.73%481.21M |
| Cash at the end | 31.68%1.35B | 106.89%1.02B | 13.86%1.03B | -32.82%492.36M | 11.69%902.65M | 20.80%732.92M | -3.93%808.15M | 21.88%606.75M | 45.22%841.2M | 3.45%497.83M |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | KPMG | -- | Ernst & Young | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.